Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
D001201:Ascites / Q000139:chemically induced; D001831:Body Temperature / Q000187:drug effects; D056486:Chemical and Drug Induced Liver Injury; D002738:Chloroquine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002845:Chromatography; D005243:Feces / Q000032:analysis; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007501:Iron / Q000097:blood; D007982:Levulinic Acids / Q000652:urine; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000188:drug therapy*; D011166:Porphyrins / Q000032:analysis / Q000652:urine; D011422:Propionates / Q000032:analysis / Q000652:urine; D011758:Pyrroles / Q000032:analysis / Q000652:urine; D013997:Time Factors
D007982:Levulinic Acids; D011166:Porphyrins; D011422:Propionates; D011758:Pyrroles; D002738:Chloroquine; D007501:Iron